As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's competitive position.

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) -- The transaction is subject to customary closing ...

To evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing.

Multiply Labs' goal is to enable scalable, high-throughput manufacturing while maintaining rigorous quality and regulatory standards.

Eli Lilly and Nvidia are putting up to $1 billion on the table to see whether generative AI can compress the decade-long slog of drug development into something closer to a software cycle. The two ...

(The Center Square) – Drug products for oncology and neurological diseases will be manufactured in a second facility Johnson & Johnson plans to open in eastern North Carolina. Nearly $80 million in ...

The eighth-largest pharmaceuticals company in the world, Swiss-based Novartis, is planning a $280 million manufacturing plant in Denton and has secured incentives from the city to do so. According to ...

HUNTSVILLE, Ala. (WAFF) - During a press conference held on Tuesday, pharmaceutical giant Eli Lilly announced that they will construct a $6 billion state-of-the-art pharmaceutical manufacturing plant ...

Eli Lilly and Company announced Tuesday it was investing more than $6 billion in a new manufacturing facility in Huntsville, Alabama. The next-generation synthetic medicine active pharmaceutical ...

HUNTSVILLE, Ala. (WHNT) — Pharmaceutical giant Eli Lilly announced on Tuesday it plans to invest more than $6 billion in a new manufacturing plant in Huntsville. Company officials said the site will ...

The global pharmaceutical market size is projected to reach nearly USD 3.03 trillion by 2034. The market is valued at USD 1.77 trillion in 2025 and is expected to grow from USD 1.88 trillion in 2026 ...